Patents by Inventor Rebecca Lew

Rebecca Lew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070042452
    Abstract: A method of assessing a subject for aberrant cardiac function is described. The method particularly involves the measurement of a plasma biomarker, namely metallopeptidase angiotensin-converting enzyme 2 (ACE2), implicated in ischaemic heart disease.
    Type: Application
    Filed: April 4, 2006
    Publication date: February 22, 2007
    Inventors: Rebecca Lew, Alexander Smith, Louise Burrell
  • Patent number: 7026280
    Abstract: The invention relates to neuroactive peptides or analogues thereof, having at least one of the biological activities of angiotensin IV, and which comprise the sequence Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe, to methods of modulating neuronal activity, and to pharmaceutical composition thereof.
    Type: Grant
    Filed: July 9, 1997
    Date of Patent: April 11, 2006
    Assignee: Howard Florey Institute of Experimental Physiology
    Inventors: Frederick A. O. Mendelsohn, Siew Yeen Chai, Ingrid Moeller, Peter G. Aldred, Ian A. Smith, Rebecca A. Lew
  • Publication number: 20020147129
    Abstract: The invention relates to neuroactive peptides or analogues thereof, having at least one of the biological activities of angiotensin IV, and which comprise the sequence Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe, to methods of modulating neuronal activity, and to pharmaceutical composition thereof.
    Type: Application
    Filed: May 13, 1999
    Publication date: October 10, 2002
    Inventors: FREDERICK A. O. MENDELSOHN, SIEW YEEN CHAI, INGRID MOELLER, PETER G. ALDRED, IAN A. SMITH, REBECCA A. LEW